EP 2035574 A1 20090318 - USE OF N-ACYLAMINOACYLPEPTIDE HYDROLASE (APEH) AS A THERAPEUTIC OR DIAGNOSTIC TARGET
Title (en)
USE OF N-ACYLAMINOACYLPEPTIDE HYDROLASE (APEH) AS A THERAPEUTIC OR DIAGNOSTIC TARGET
Title (de)
VERWENDUNG VON N-ACYLAMINOACYLPEPTID-HYDROLASE (APEH) ALS THERAPEUTISCHES ODER DIAGNOSTISCHES ZIEL
Title (fr)
UTILISATION DE LA N-ACYLAMINOACYLPEPTIDE HYDROLASE (APEH) COMME CIBLE THÉRAPEUTIQUE OU DIAGNOSTIQUE
Publication
Application
Priority
- EP 2007005118 W 20070611
- EP 06012459 A 20060617
- EP 07725942 A 20070611
Abstract (en)
[origin: WO2007147496A1] The invention provides a human APEH which is associated with the cardiovascular diseases, cancer, inflammation, hematological diseases, neurological diseases and urological diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular diseases, cancer, inflammation, hematological diseases, neurological diseases and urological diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of APEH as well as pharmaceutical compositions comprising such compounds.
IPC 8 full level
C12Q 1/37 (2006.01); G01N 33/574 (2006.01)
CPC (source: EP)
C12Q 1/37 (2013.01); G01N 33/574 (2013.01); G01N 2500/00 (2013.01); G01N 2800/34 (2013.01)
Citation (search report)
See references of WO 2007147496A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
DOCDB simple family (application)
EP 2007005118 W 20070611; EP 07725942 A 20070611